De Novo closes $300m health tech fund

The California venture capital firm closed its third fund on $300m, to be used for investments in the medical technology and biotechnology sectors.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this